Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe

David R. Coghill (Lead / Corresponding author), Tobias Banaschewski, Peter Nagy, Isabel Hernández Otero, César Soutullo, Brian Yan, Beatriz Caballero, Alessandro Zuddas

    Research output: Contribution to journalArticlepeer-review

    16 Citations (Scopus)
    170 Downloads (Pure)

    Fingerprint Dive into the research topics of 'Long-Term Safety and Efficacy of Lisdexamfetamine Dimesylate in Children and Adolescents with ADHD: A Phase IV, 2-Year, Open-Label Study in Europe'. Together they form a unique fingerprint.

    Medicine & Life Sciences